Time: 0730 - 0815 (breakfast served at 0715)
Speakers: Dr. Matthew Parker, Prof. Mandana Nikpour, Dr John Mackintosh
Boehringer Ingelheim invites you to join our expert panel chaired by Prof. Mandana Nikpour to discuss the essential role of rheumatologists in the management of interstitial lung disease in connective tissue diseases (CTD-ILD). Together, we will explore the critical role of the multidisciplinary team in the diagnosis and management of CTD-ILD patients.
Time: 0730 - 0815 (breakfast served at 0715)
Speakers: A/Prof Mona Marabani, Dr Andrew Foote, Dr Hanish Bagga
In line with the goals of both clinicians and their patients, recent recommendations advocate for achieving low disease activity or remission in the management of psoriatic arthritis (PsA) and axial spondyloarthritis (axSpA)1-5. However, a consensus on which clinical measures are most effective for assessing these targets is lacking. While the outcomes required for clinical trials offer robust measurements of defined treatment targets, they may not always address the practical considerations necessary for evaluating patients in a real-world setting. In this context, how can incorporating elements of higher treatment targets enhance patient outcomes and treatment success? UCB Australia cordially invites you to participate in an interactive discussion on the most valuable clinical outcomes across PsA and axSpA. We will explore how your patients can benefit from striving for the measures that matter most.
Time: 1245 - 1345 (Lunch served at 1230)
Chair: Prof Rebecca Grainger
Speakers: Prof Lai-Shan Tam & A/Prof Andrew Östör
Treating patients with rheumatic diseases is challenging and influenced by many factors that require a tailored approach. The international panel of experts will highlight and discuss key factors that can influence the optimal treatment approach in RA & SpA. You can also look forward to an update to emerging real-world evidence in this space and the importance of this data to inform clinical decision making.
Time: 0730 - 0815 (breakfast served at 0715)
Chair: A/Prof Andrew Östör
Speakers: George Tambassis & Dr Queenie Luu
Arrotex invites you to join our export panel as they discuss:
Time: 0730 - 0815 (breakfast served at 0715)
Speakers: A/Prof. Yi Yang & Dr Tim Bennett
Making the Invisible Visible is a collaborative case-based presentation between rheumatology and spinal surgeon experts. Hear the experts discuss current diagnostic challenges and approaches in SpA using real patient cases.
Time: 1245 - 1345 (Lunch served at 1230)
Speakers: Professor Stephen Hall, Dr Hugh De Lautour, Samantha Shearman, Dr Stephanie Brown
PsA presents a complex challenge, requiring a multifaceted approach for effective management. Novartis symposium brings together experts in rheumatology, dietetics and physiotherapy to explore a holistic approach to PsA management.
Time: 1245 - 1345 (Lunch served at 1230)
Speakers: Dr Mark Friswell
Numerous challenges are encountered in rheumatology in the care of adolescents and young adults. This session will present real-world case studies and an overview of the research findings in this area. Learn more about transitional care at the Women and Children’s Hospital in Adelaide, the challenges encountered, and participate in an engaging discussion on how rheumatologists caring for paediatric patients and those caring for adults can partner to improve this transition.
2024 Joint ARA and NZRA Annual Scientific Meeting
Meeting organisers: The Conference Company
Email: nzra-ara2024@theconferencecompany.com
Phone (within Australia): 1800 193 405
Phone (New Zealand): +64 9 360 1240
Copyright © 2023 The Conference Company
Site Designed & Developed by The Conference Company